Guest Post -- Recent Software Case Gives Important Lessons for Biotech

by McDonnell Boehnen Hulbert & Berghoff LLP
Contact

[authors: Nicholas Vincent* and Anthony D. Sabatelli**]

On September 13, the Federal Circuit held that a series of ordered combination of steps related to lip-synch software did not constitute an abstract idea, and was subsequently patent eligible under §101 (McRO, Inc. v. Bandai Namco Games America).  This decision reversed and remanded an earlier decision issued by the United States District Court for the Central District of California in McRO, Inc. v. Sony Computer Entertainment America, LLC.  This case, which was followed closely by the IT community, also has important, positive implications for the patent eligibility of biotech inventions.

The earlier decision asserted in 2014 that U.S. Patent Nos. 6,307,576 ('576) and 6,611,278 ('278) were invalid, as they were not based on patentable claims under § 101.  In particular, the decision held that, although there were novel portions of the invention, they were claimed too broadly, thereby invalidating the patents.  Patents '576 and '278 share the same title ("Method for Automatically Animating Lip Synchronization and Facial Expression of Animated Characters").

In the current ruling, the Court sought to apply the two-step Alice test, a test that first addresses whether the claims are directed toward an abstract idea, and if they are, then considers whether the claims recite something "significantly more" that makes the claims patent-eligible.  In applying the first step of the Alice test, the Court found that representative Claim 1 of '576, which focuses on particular improvements in computer animation, is not directed towards an abstract idea.  In addition, the Court went on to state that the advancement represents a significant improvement on the prior art.  As a result, step one of the Alice test is not met, and the software-encoded combination of steps for the lip-synch software is therefore patent eligible under § 101.  Interestingly, the Court did not reach step two of the test, showing that it is possible to pass the Alice test on step one alone, giving hope to future claims that may face Alice-related challenges.

Interestingly, McRO maintained in its position that the claims are patent eligible because they constitute an improvement in animation, regardless of whether they are claiming an abstract idea.  In fact, McRO claimed that Diamond v. Diehr was the relevant precedent since the final product is a 3-D video and not an abstract idea.  This was challenged by the defendants who claimed that a past case, Parker v. Flook, was most pertinent to the patentability of the lip-synch software mainly because McRO was patenting what the defendants claimed was an unpatentable algorithm.  The Court, as previously stated, held otherwise.

The highly anticipated McRO decision comes on the tails of three recent decisions also by the Federal Circuit:  the Rapid Litigation Management, Enfish, and BASCOM decisions, the latter two of which are also from the computer/ software realm, and not the biotech world.  Together, these decisions are expected to play an important role in guiding the formation of patent-eligible claims that, historically, would have likely been considered patent-ineligible under the Alice test.  Specifically, and in relation to the McRO decision, claiming improvements on prior art seems to be both a promising and successful way of overcoming potential Alice-related challenges.

Together, McRO, Rapid Litigation Management, Enfish, and BASCOM give the biotech field important guidance in developing patent-eligible biotech claims.  Not only does this new developing precedent grant the potential for expanded patentability, but it also provides a clearer means to overcoming Alice-related challenges in the future.  The message for biotech is to craft claims and set up the background in the specification to clearly point out the importance and improvements of the technology.  Clearly, if there is an improvement over the state of the art, this bodes well for patent eligibility.

For biotechnology, the implication of expanded patentability is particularly promising; as biotechnology research engages more frequently with larger data sets and uses more complex, quantitative, and software-based approaches to answer questions, computing and software will play a larger role in these research endeavors.  Computers and software are becoming increasingly more enmeshed with many areas of biotech research and developments.  Moving forward, the ability to successfully defend algorithm-based patents against Alice challenges on the tails of McRO will likely focus primarily on the improvements over prior art, a shift from an earlier focus on the abstract nature of the innovation in question.

* Nicholas Vincent is a Technology Specialist at Dilworth IP
** Dr. Sabatelli is a Partner with Dilworth IP

Written by:

McDonnell Boehnen Hulbert & Berghoff LLP
Contact
more
less

McDonnell Boehnen Hulbert & Berghoff LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.